Wnt10

Wnt10 refers mainly to the related ligands WNT10A and WNT10B, which regulate organ development, cell proliferation, differentiation, and tissue patterning through Wnt/β-catenin signaling[1]. Mechanistically, WNT10A supports ectoderm-derived tissues by maintaining β-catenin activity, epithelial progenitor proliferation, and KLF4-mediated differentiation[2]. In disease genetics, WNT10A variants associate with ectodermal dysplasia, selective tooth agenesis, abnormal tooth shape, and stronger dental severity in bi-allelic cases[3][4]. Compared with WNT10A, WNT10B shows clearer experimental relevance to skeletal and adipose biology, because Wnt10b transgenic mice show increased bone mass and resistance to age- or estrogen-deficiency bone loss[5]. Wnt10b also shifts mesenchymal cell fate toward osteoblastogenesis by inducing Runx2, Dlx5, and osterix while suppressing adipogenic regulators[5]. In tooth models, combined Wnt10a/Wnt10b mutation causes reduced tooth number and severe root or enamel hypoplasia, supporting functional redundancy between the isoforms[1]. Therefore, Wnt10 research should distinguish WNT10A-focused ectodermal and dental models from WNT10B-focused bone, adipogenesis, and β-catenin pathway models[1][5].